OBJECTIVE: This study aims to unveil the role and mechanism of histone deacetylase SIRT1 in modulating fatty acid binding protein 4 (FABP4) stability and its impact on hepatic fibrosis and ferroptosis in non-alcoholic fatty liver disease (NAFLD). METHODS: A murine NAFLD fibrosis model was induced by a Western diet combined with CCl(4) injection. Mice received adenoviruses carrying oe-SIRT1 or sh-FABP4 three days before modeling. In vitro, NCTC 1469 hepatocytes were exposed to palmitic acid (PA) and transfected with oe-SIRT1 or oe-FABP4. Histopathology was assessed by HE, Masson, and Sirius red staining, and α-SMA by immunohistochemistry. Biochemical assays and molecular analyses measured liver injury markers, ferroptosis-related proteins, oxidative stress indices, and SIRT1/FABP4 expression. Cell viability, death, and lipid deposition were evaluated by CCK-8, LDH release, and Oil Red O staining. Co-IP and CHX chase assays examined SIRT1âFABP4 interaction, acetylation, and protein stability. RESULTS: NAFLD mice showed decreased SIRT1 and increased FABP4, with lipid degeneration, collagen deposition, α-SMA upregulation, and aggravated ferroptosis. Either SIRT1 overexpression or FABP4 knockdown alleviated inflammation, fibrosis, and ferroptosis in vivo. In PA-treated hepatocytes, cell viability declined, LDH release and lipid deposition increased, AST/ALT rose, ferroptosis intensified, SIRT1 was suppressed, and FABP4 was upregulated. Enhancing SIRT1 reduced FABP4 expression, attenuated lipid accumulation, and limited ferroptosis. Mechanistically, SIRT1 interacted with FABP4 to decrease its acetylation, thereby lowering FABP4 stability. FABP4 overexpression partially reversed the protective effect of SIRT1, promoting ferroptosis and lipid deposition. CONCLUSION: SIRT1 reduces FABP4 acetylation and stability, thereby suppressing ferroptosis and hepatic fibrosis in NAFLD. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10238-025-02029-8.
SIRT1-mediated FABP4 destabilization attenuates fibrosis and ferroptosis in non-alcoholic fatty liver disease.
SIRT1 介导的 FABP4 不稳定可减轻非酒精性脂肪肝疾病中的纤维化和铁死亡。
阅读:3
作者:
| 期刊: | Clinical and Experimental Medicine | 影响因子: | 3.500 |
| 时间: | 2026 | 起止号: | 2026 Feb 6; 26(1):129 |
| doi: | 10.1007/s10238-025-02029-8 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
